Skip to main content
. 2020 Sep 29;15:268. doi: 10.1186/s13023-020-01525-2
Name (First, MI, Last) Institution, Country
Melanie Blank Food and Drug Administration, USA
Michelle Campbell Food and Drug Administration, USA
John O. Clarke Stanford University, USA
Raymond Comenzo Tufts Medical Center, USA
Laura M. Dember University of Pennsylvania, USA
Angela Dispenzieri Mayo Clinic, USA
Sharmila Dorbala Brigham and Women’s Hospital, USA
Preston Dunnmon Food and Drug Administration, USA
Douglas V. Faller Takeda Pharmaceutical Co., Inc., USA
Rodney H. Falk Harvard Medical School, USA
Nicole Gormley Food and Drug Administration, USA
Kristen Hsu Amyloidosis Research Consortium, USA
Carol D. Karp Prothena Biosciences, USA
Heather Landau Memorial Sloan Kettering Cancer Center, USA
Jessica L. Lee Food and Drug Administration, USA
Isabelle Lousada Amyloidosis Research Consortium, USA
Michelle L. Mauermann Mayo Clinic, USA
Mathew Maurer Columbia University, USA
Vaishali Sanchorawala Boston University School of Medicine, USA
James Signorovitch Analysis Group Inc., USA
Kimberly Smith Food and Drug Administration, USA
Ashutosh D. Wechalekar University College London, UK
Brendan M. Weiss Janssen Research & Development, USA
Michelle K. White Optum, USA